Profile data is unavailable for this security.
About the company
Uni-Bio Science Group Limited is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.
- Revenue in HKD (TTM)484.72m
- Net income in HKD70.88m
- Incorporated2001
- Employees407.00
- LocationUni-Bio Science Group Ltd13/F, Public Bank Centre,120 Des Voeux Road Central, Central Hong KongHKG
- Phone+852 31023232
- Fax+852 31023737
- Websitehttps://www.uni-bioscience.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Modern Chinese Medicine Group Co Ltd | 371.01m | 52.62m | 237.00m | 191.00 | 4.50 | 0.4648 | 4.00 | 0.6388 | 0.0877 | 0.0877 | 0.6184 | 0.8499 | 0.6681 | 5.45 | 3.80 | 1,942,477.00 | 9.47 | 20.76 | 10.75 | 25.82 | 30.28 | 41.02 | 14.18 | 20.11 | 7.98 | 206.12 | 0.0002 | 2.54 | -13.91 | 14.67 | -44.44 | 0.2303 | 96.96 | -- |
Wai Yuen Tong Medicine Holdings Limited | 1.36bn | 36.42m | 253.15m | 1.96k | 7.43 | 0.1184 | 1.48 | 0.1863 | 0.0303 | 0.0303 | 1.13 | 1.90 | 0.2014 | 0.424 | 22.81 | 700,208.60 | 0.8907 | -0.0733 | 1.54 | -0.1196 | 49.08 | 42.52 | 4.42 | -0.456 | 0.5663 | 1.49 | 0.3196 | 0.00 | -7.55 | 8.75 | 81.16 | -- | -12.06 | -- |
Shenzhen Neptunus Intrlng Bi tchnq CoLtd | 1.15bn | 26.02m | 270.16m | 1.44k | 10.38 | 0.2759 | 5.20 | 0.2353 | 0.0155 | 0.0155 | 0.6843 | 0.5836 | 0.7437 | 3.03 | 6.51 | 795,173.40 | 1.01 | 3.46 | 1.57 | 5.13 | 41.81 | 49.14 | 1.36 | 4.29 | 1.95 | -- | 0.0811 | 0.00 | 7.92 | 4.19 | -55.60 | -12.89 | -11.10 | -- |
PuraPharm Corp Ltd | 406.86m | -106.08m | 304.84m | 662.00 | -- | 1.99 | -- | 0.7493 | -0.2685 | -0.2685 | 1.03 | 0.3871 | 0.4374 | 1.04 | 4.19 | 614,590.60 | -11.40 | -9.20 | -34.00 | -19.70 | 53.24 | 59.44 | -26.07 | -19.33 | 0.3046 | -2.28 | 0.7349 | -- | -9.20 | -11.41 | 11.76 | -- | -13.68 | -- |
Hin Sang Group (Interntnl) Hldng Co Ltd | 92.79m | -35.72m | 316.62m | 265.00 | -- | 1.44 | -- | 3.41 | -0.0327 | -0.0327 | 0.085 | 0.202 | 0.1524 | 2.29 | 9.49 | 366,766.80 | -5.81 | -4.06 | -8.74 | -5.26 | 55.95 | 61.98 | -38.14 | -20.98 | 0.1129 | -1.15 | 0.5766 | -- | -32.42 | -15.45 | -315.54 | -- | -36.30 | -- |
Uni-Bio Science Group Ltd | 484.72m | 70.88m | 456.11m | 407.00 | 6.64 | 1.81 | 5.20 | 0.941 | 0.0111 | 0.0111 | 0.0762 | 0.041 | 1.38 | 2.62 | 13.50 | 1,190,953.00 | 20.18 | 1.46 | 28.50 | 1.97 | 81.04 | 80.59 | 14.62 | 1.23 | 1.76 | 97.93 | 0.1796 | 0.00 | 10.08 | 29.08 | 84.04 | -- | 84.98 | -- |
Tianda Pharmaceuticals Ltd | 532.09m | -24.16m | 520.31m | 863.00 | -- | 0.8788 | 40.88 | 0.9779 | -0.0112 | -0.0112 | 0.2475 | 0.2754 | 0.5306 | 4.88 | 4.37 | 616,557.40 | -2.49 | -- | -3.84 | -- | 48.02 | -- | -4.70 | -- | 0.8907 | -10.16 | 0.161 | -- | -- | -- | -- | -- | -- | -- |
Kintor Pharmaceutical Ltd | 0.00 | -1.14bn | 541.47m | 225.00 | -- | 1.10 | -- | -- | -2.66 | -2.66 | 0.00 | 1.10 | 0.00 | 0.1448 | -- | 0.00 | -72.55 | -50.15 | -89.09 | -58.43 | -- | -27.62 | -- | -10,511.41 | 2.10 | -- | 0.3566 | -- | -- | -- | -11.15 | -- | -32.49 | -- |
Clover Biopharmaceuticals Ltd | 42.33m | -149.39m | 551.25m | 387.00 | -- | -- | -- | 13.02 | -0.1196 | -0.1196 | 0.034 | -0.6096 | 0.0116 | 0.0098 | 0.7449 | 109,375.50 | -4.08 | -- | -16.40 | -- | 61.75 | -- | -352.92 | -- | 0.5281 | -1.45 | -- | -- | -- | -- | 94.35 | -- | -- | -- |
Antengene Corporation Ltd | 72.57m | -626.68m | 668.14m | 201.00 | -- | 0.540 | -- | 9.21 | -1.02 | -1.02 | 0.118 | 1.83 | 0.0358 | 0.9773 | 3.41 | 361,066.70 | -30.91 | -53.57 | -36.46 | -58.94 | 81.74 | -- | -863.51 | -1,987.01 | 6.43 | -- | 0.1491 | -- | -57.97 | -- | 3.38 | -- | -- | -- |
Lee's Pharmaceutical Holdings Ltd | 1.05bn | 16.70m | 683.05m | 1.06k | 40.90 | 0.335 | 4.38 | 0.6487 | 0.0284 | 0.0284 | 1.79 | 3.46 | 0.3713 | 1.83 | 10.75 | 996,247.90 | 0.7033 | 13.33 | 0.88 | 17.76 | 52.35 | 61.92 | 1.89 | 36.20 | 0.5526 | 3.90 | 0.0943 | 3.59 | -14.61 | -1.53 | -67.44 | -47.49 | -12.19 | -31.34 |